investors.biomarin.comBioMarin Pharmaceutical Investor Relations

Overview News EventsPresentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Leadership Team Board of Directors Committee Composition Contact the Board Resources Investor FAQs Investor Email Alerts Investor Contacts INVESTORS AND MEDIA Transforming Lives Through Genetic Discovery We seek to make a big difference in genetic disorders. At BioMarin, through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. $2 Billion in 2022 FY Total Revenues 78 Countries Commercial Footprint World-class Capabilities Manufacturing, RD, Regulatory, and Commercial "Core 4" Product Framework Genetic, Targeted, Assessable, Transformational Learn moreLatest News View All News Latest Events View All Events Latest Quarterly Reports View All Financial Reports A commitment to corporate responsibility. We are committed to conducting our operations and managing our products in a responsible manner and in accordance with applicable laws, rules, and regulations. We regularly review our operations to improve efficiency and reduce environmental impact where appropriate. Learn More We take on the biggest challenges in rare disease. Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. Learn More Contact Us Investor RelationsCONTACT US BY PHONE 415-455-7558[email protected] MediaPressCONTACT US BY PHONE (415) 506-6700[email protected] Quick Links SEC Filings Investor FAQs Contact Us Derivative Settlement STOCKHOLDERS AS OF RECORD DATE FOR THE 2024 ANNUAL MEETING Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Biomarin Pharmaceutical Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Biomarin Pharmaceutical Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote EventsPresentations Unsubscribe Email Alert Sign Up Confirmation Navigate Our Motivation Our Treatments Our Company InvestorsMedia About Our History Our Products Our Pipeline Leadership Team Board of Directors Diversity, EquityInclusion Contact Global Contact Information Our Locations Report a Product Complaint Report Adverse Event Publication Data Request FundingSupport Connect Careers LinkedIn Facebook Instagram YouTube © 2024 BioMarin. - All rights reserved Powered By Q4 Inc. 5.122.0.3 Privacy Policy | Terms of Use | Site Map | Supplier Information | Slavery Act Statement | Glossary | Contact Us | Cookie...